Equine IL-1alpha quantitates equine IL-1alpha in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant equine IL-1alpha.
Equine IL-1alpha quantitates equine IL-1alpha in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant equine IL-1alpha.
Equine IL-1alpha quantitates equine IL-1alpha in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant equine IL-1alpha.
L-IL-1 alpha (interleukin-1 alpha) is a pro-inflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. The IL-1 alpha is encoded by the IL1A gene and sends signals via two receptors, the IL-1RI and the IL-1RII, both of which are shared with the IL-1 beta. L-IL1A is located on the q arm of chromosome 2 at position 13. The IL-1 alpha plays an important role in the innate defence of the host by triggering the production of other pro-inflammatory cytokines in the target cells and acute phase responses. The activity of the IL-1 alpha may be moderated by the IL-1 receptor antagonist (IL-1RA), a protein produced by many cell types that blocks receptor binding by competitive inhibition. The IL-1 alpha is a pleiotropic cytokine involved in various immune responses and inflammatory processes, and in haematopoiesis. In addition, the IL-1 alpha is produced by monocytes and macrophages in the form of a proprotein that is proteolytically treated and released in response to cell lesions and induces apoptosis. The IL1A gene and eight other genes from the interleukin 1 family form a group of cytokine genes on chromosome 2. The activity of NF-kappaB and mitogen-activated kinase proteins is regulated by the ZIL1 alpha. The IL-1 alpha can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2) as well as improve nitric oxide (NO) production. High levels of IL-1 alpha are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis.
Sensitivity
Sensitivity of the dosage: 0.82 pg/mL.
Measurement range
Dose range: 0.82 to 200 pg/mL.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: IL-1 alpha.
Samples
Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).